Fetal Assessment, Maternal Hormonal Changes, and Clinical Signs of Pregnancy
Amniocentesis: Fetal Assessment and Diagnostic Procedure
- Definition and Procedure: Amniocentesis involves inserting a needle through the abdomen into the amniotic sac to collect amniotic fluid. * Uses ultrasound guidance to ensure proper needle placement. * The needle is connected to a syringe used to draw back the fluid for testing.
- Timing of Procedure: * Typically performed around weeks of pregnancy to detect genetic or chromosomal abnormalities. * Performed later in pregnancy to evaluate fetal health and lung maturity.
- Detection Capabilities: * Genetic or chromosomal abnormalities. * Fetal lung maturity. * Infection. * Fetal distress. * Abnormal fetal lab values.
- Risks Involved (Invasive Procedure): * Infection: Considered the number one risk. * Bleeding: Resulting from abdominal entry. * Trauma: Potential harm to the baby. * Fluid Loss: Risk of rupture and subsequent leaking of amniotic fluid.
- Nursing Responsibilities: * Informed Consent: Nurses must ensure the patient has signed the consent form. If the patient expresses a lack of understanding regarding the procedure, the Primary Care Provider (PCP) must inform them before the nurse obtains consent. * Monitoring: Fetal heart tones must be monitored before and after the procedure to ensure the fetus is not in distress. * Observation: Monitor for signs of potential risks, including bleeding, fluid leakage, or fever.
- Patient Indications (Who Should Consider It): * Pregnant patients over the age of (due to higher risk of chromosomal abnormalities/birth defects). * Families with a history of genetic disorders. * Patients with abnormal prenatal screening results. * Patients with gestational or preexisting diabetes (checking for fetal lung maturity before delivery).
- Diagnostic Classification: Unlike many other screening tools, amniocentesis is a diagnostic test that provides definitive information.
Nuchal Translucency Test
- Definition: An ultrasound measurement of the fluid-filled space at the back of the baby's neck, known as the nuchal fold.
- Timing: Performed between to weeks of pregnancy.
- Procedure Preparation: Mothers are encouraged to drink fluids to maintain a full bladder. A full bladder improves visualization by pushing the uterus up.
- Measurements: * Normal: Generally up to . * Abnormal: Increased thickness is defined as measurements greater than .
- Purpose: This is a screening test (not a diagnostic test) for: * Down syndrome. * Trisomy . * Trisomy . * Turner syndrome. * Congenital heart defects.
- Follow-up: Because it only indicates an increased risk, abnormal results require further diagnostic testing, such as amniocentesis.
Chorionic Villus Sampling (CVS)
- Definition: A diagnostic test that involves removing a small sample of placental tissue from the chorion (part of the developing placenta).
- Timing: Performed between to weeks of pregnancy. This allows for earlier diagnosis compared to amniocentesis (usually weeks).
- Methods of Access: * Transcervical: Through the cervix. * Transabdominal: Through the abdomen.
- Indications: Detection of genetic abnormalities such as Down syndrome, trisomy , trisomy , and specific inherited disorders.
- Risks: * Infection and bleeding. * Miscarriage: CVS has a slightly higher incidence of miscarriage compared to amniocentesis because it is more invasive (actually removing tissue rather than just fluid).
- Post-Procedure Nursing Actions: * Monitor for bleeding, fluid leakage, and signs of infection. * Patient Education: Instruct patients to report fever, heavy bleeding, or fluid leakage immediately.
Biophysical Profile (BPP)
- Definition: A prenatal test that evaluates overall fetal well-being by combining ultrasound with a nonstress test (NST).
- Timing: Most commonly performed during the third trimester.
- The Five Components of BPP: 1. Nonstress Test (NST): Monitors fetal heart tones to see if the heart rate increases with fetal movement (a reassuring sign of health). 2. Fetal Breathing Movements: Visualization of practice breathing movements. 3. Fetal Body Movements: Evaluation of gross body movements (arms, legs, trunk). 4. Fetal Muscle Tone: Evaluation of flexion and extension (e.g., opening and closing of hands). 5. Amniotic Fluid Volume: Assessment of whether there is an adequate amount of fluid surrounding the baby.
- Scoring System: * Each of the five categories is worth points ( points if absent/abnormal; points if normal). * points: Normal result; baby is doing well. * points: Questionable result; may require repeated testing or closer monitoring. * points: Abnormal; concerning for possible fetal compromise or distress.
- Nursing and Patient Education: * Suggest the patient eat before the test to increase fetal movement for the NST portion. * Explain that the procedure is noninvasive (ultrasound and belly monitors). * Document fetal movement, heart rate findings, and the final BPP score. * Indications for BPP: Pregnancy-induced hypertension (preeclampsia), maternal diabetes, post-term pregnancy, previous complications, or suspected placental insufficiency (decreased oxygen delivery).
- Detection of Placental Insufficiency: Suspected if heart rate drops are seen on a contraction stress test (CST) or NST. Specifically, late decelerations (heart rate drops during or after a contraction) signify the baby is not tolerating contractions and is not receiving enough oxygen.
- Duration: The test takes approximately minutes, potentially longer if the baby is less active.
Hormonal Changes During Pregnancy
Estrogen
- Functions: * Stimulates uterine growth to support the fetus. * Increases blood flow to the uterus and placenta. * Prepares breasts for lactation (contributes to enlargement and darkening of nipples/areola). * Note: Darkening of the areola may help the newborn see and smell the breast for natural latching (breast crawl).
- Implications: Decreased estrogen can lead to placental insufficiency and decreased oxygen for the baby.
- Postpartum: Estrogen levels drop upon the expulsion of the placenta. In non-breastfeeding mothers, levels rise again around weeks postpartum.
Progesterone
- Source: Produced mainly by the placenta.
- Functions: * Maintains a thick, healthy uterine lining. * Relaxes smooth muscle throughout the body. * Helps prevent premature uterine contractions.
- Postpartum: Progesterone levels drop sharply after the placenta is delivered.
- Associated Mood Changes: Sudden drops in hormones (estrogen and progesterone) contribute to mood swings and postpartum depression.
Prolactin
- Source: Anterior pituitary gland (brain).
- Function: Stimulates breast milk production.
- Regulation: Released via nipple stimulation. Milk production works on a supply and demand basis—more frequent nursing results in more prolactin and more milk.
- Hormonal Interactions: Elevated prolactin suppresses estrogen levels, which often delays ovulation and the return of menstruation in breastfeeding mothers.
Determination of Pregnancy: Signs and Symptoms
Presumptive Signs (Subjective)
These are symptoms the patient reports. They suggest pregnancy but can be caused by other conditions like stress or illness.
- Amenorrhea: Missed period (earliest common sign; also caused by weight change or endocrine disorders).
- Nausea and Vomiting (Morning Sickness): Typically begins around weeks due to increased estrogen. Can occur at any time of day.
- Hyperemesis Gravidarum: Severe, continuous vomiting leading to dehydration.
- Breast Changes: Tenderness, enlargement, feeling heavy, sore, or tingling.
- Fatigue: Increased tiredness.
- Frequent Urination: Caused by increased renal blood flow and pressure on the bladder.
- Food Cravings and Aversions: Sudden desire for specific foods or intolerance to others (e.g., aversion to the smell of meat or eggs).
Probable Signs (Objective)
These are observable by the examiner and strongly suggest pregnancy but are not definitive.
- Positive Pregnancy Test: Detects hCG. * Qualitative (Urine): Provides a positive or negative result. * Quantitative (Blood): Provides the specific amount of hCG. * Note: hCG can be elevated in other conditions such as carcinomas.
- Enlarged Uterus: Observable during pelvic examination (can also be caused by cancer or fibroids).
- Hagar Sign: Softening of the lower uterine segment/cervix ( weeks).
- Chadwick Sign: Bluish-purple discoloration of the cervix and vaginal walls due to increased vascularity/blood flow.
- Abdominal Enlargement: Noticeable in the second trimester.
- Ballottement: Observed between weeks; the examiner taps the cervix, and the fetus rebounds upward and returns.
Positive Signs (Definitive)
These provide absolute confirmation that a fetus is present and cannot be caused by other conditions.
- Fetal Heartbeat: Heard with a Doppler device around weeks. Normal rate is .
- Fetal Movement: Palpated by a healthcare provider later in pregnancy.
- Visualization of the Fetus: Seen via ultrasound (gestational sac, fetal movement, or cardiac activity). This is one of the earliest definitive confirmation methods.
Questions & Discussion
- Student Question on Examination Consistency: A student noted missing an assignment question regarding who should perform abdominal exams. They mentioned the recommendation is that the same person (nurse or doctor) should perform the abdomen measurements at each appointment because they will remember the patient from previous visits and provide more consistent measurements. The instructor noted that in the "real world," patients often see whoever is available, though the academic answer may differ.
- Fetal Movement Awareness: It was discussed that while multiparous women (those who have been pregnant before) might feel movement earlier, it is often because they know what they are feeling for, whereas first-time mothers may feel it but not recognize it as fetal movement.